Recently, U.S. Food and Drug Administration (FDA) issued Warning Letters to pharmaceutical companies and their outsourcing partners have resulted to focus on clinical oversight. The letters have galvanized sponsors to take a close look at their ability to withstand such regulatory scrutiny internally, and to develop proactively their internal capabilities and infrastructure
Carcinoid Syndrome - Research Perspective
Carcinoid syndrome is a collective of symptoms that occurs in patients with Carcinoid tumor. It is caused by excessive endogenous secretion of hormones mainly serotonin and kallikrein. The syndrome includes flushing and diarrhea, and, less frequently, heart failure and bronchoconstriction.